Swiss pharmaceutical company Roche has announced that a new antibiotic, zosurabalpin, is progressing to phase 3 testing.

Real-time index price for S&P GSCI Index (GNX), along with buy or sell indicators, analysis, charts, historical performance, ...

Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of antibiotics against drug-resistant bacteria. The team, led by scientists at the ...

Roche (RHHBY) is planning to move a new antibiotic into late stage clinical trials after early studies showed it had ...

A research team affiliated with UNIST has unveiled a novel extracorporeal blood purification technology that captures and ...

Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...

An experimental antibiotic zosurabalpin to fight deadly superbug has entered the final human trials. This development could ...

Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...

Abstract Extracorporeal hemoadsorption for treating bacteremia has exhibited limited success due to the lack of a clear strategy for effectively ...

According to a new study, researchers have developed a 3D-printed stent designed to treat urinary tract infections (UTIs) ...

Recce Pharmaceuticals secures patent acceptance in China for synthetic anti-infectives as it targets growing global health ...

Zevtera, an advanced-generation cephalosporin, is available for treating Staphylococcus aureus bacteremia and 2 other types ...